abstract |
The invention relates to chimeric pseudo-virus particles (VLPs) containing and presenting epitopes and an antigen from Zika virus (ZIKV); and methods of creating and producing said chimeric VLPs, and their applications, including but not limited to vaccines, diagnostics, clinical studies, assay development, and antibody discovery. |